BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 30680790)

  • 1. Phenotypic and genotypic analysis of amelanotic and hypomelanotic melanoma patients.
    Rayner JE; McMeniman EK; Duffy DL; De'Ambrosis B; Smithers BM; Jagirdar K; Lee KJ; Soyer HP; Sturm RA
    J Eur Acad Dermatol Venereol; 2019 Jun; 33(6):1076-1083. PubMed ID: 30680790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Incident Amelanotic Melanoma With Phenotypic Characteristics, MC1R Status, and Prior Amelanotic Melanoma.
    Vernali S; Waxweiler WT; Dillon PM; Kanetsky PA; Orlow I; Luo L; Busam KJ; Kricker A; Armstrong BK; Anton-Culver H; Gruber SB; Gallagher RP; Zanetti R; Rosso S; Sacchetto L; Dwyer T; Cust AE; Ollila DW; Begg CB; Berwick M; Thomas NE;
    JAMA Dermatol; 2017 Oct; 153(10):1026-1031. PubMed ID: 28746718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline and somatic albinism variants in amelanotic/hypomelanotic melanoma: Increased carriage of TYR and OCA2 variants.
    Rayner JE; Duffy DL; Smit DJ; Jagirdar K; Lee KJ; De'Ambrosis B; Smithers BM; McMeniman EK; McInerney-Leo AM; Schaider H; Stark MS; Soyer HP; Sturm RA
    PLoS One; 2020; 15(9):e0238529. PubMed ID: 32966289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amelanotic/hypomelanotic melanoma: clinical and dermoscopic features.
    Pizzichetta MA; Talamini R; Stanganelli I; Puddu P; Bono R; Argenziano G; Veronesi A; Trevisan G; Rabinovitz H; Soyer HP
    Br J Dermatol; 2004 Jun; 150(6):1117-24. PubMed ID: 15214897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High naevus count and MC1R red hair alleles contribute synergistically to increased melanoma risk.
    Duffy DL; Lee KJ; Jagirdar K; Pflugfelder A; Stark MS; McMeniman EK; Soyer HP; Sturm RA
    Br J Dermatol; 2019 Nov; 181(5):1009-1016. PubMed ID: 30820946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinically amelanotic or hypomelanotic melanoma: Anatomic distribution, risk factors, and survival.
    Wee E; Wolfe R; Mclean C; Kelly JW; Pan Y
    J Am Acad Dermatol; 2018 Oct; 79(4):645-651.e4. PubMed ID: 30241625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological, dermoscopic features and circumstances of diagnosis of amelanotic or hypomelanotic melanoma: A prospective multicentric study in the French private medical sector.
    Lorier Roy E; Gourhant JY; Derancourt C; Jouan N; Dupuy A; Séi JF;
    Ann Dermatol Venereol; 2024 Mar; 151(1):103249. PubMed ID: 38422599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of clinicopathologic features and survival of histopathologically amelanotic and pigmented melanomas: a population-based study.
    Thomas NE; Kricker A; Waxweiler WT; Dillon PM; Busman KJ; From L; Groben PA; Armstrong BK; Anton-Culver H; Gruber SB; Marrett LD; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Venn A; Kanetsky PA; Orlow I; Paine S; Ollila DW; Reiner AS; Luo L; Hao H; Frank JS; Begg CB; Berwick M;
    JAMA Dermatol; 2014 Dec; 150(12):1306-314. PubMed ID: 25162299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amelanotic/Hypomelanotic melanoma--is dermatoscopy useful for diagnosis?
    Zalaudek I; Argenziano G; Kerl H; Soyer HP; Hofmann-Wellenhof R
    J Dtsch Dermatol Ges; 2003 May; 1(5):369-73. PubMed ID: 16285302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CDKN2A and MC1R analysis in amelanotic and pigmented melanoma.
    Ghiorzo P; Pastorino L; Pizzichetta MA; Bono R; Queirolo P; Talamini R; Annessi G; Bruno W; Nasti S; Gargiulo S; Battistuzzi L; Sini MC; Palmieri G; Scarrà GB;
    Melanoma Res; 2009 Jun; 19(3):142-5. PubMed ID: 19339902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dermatoscopy of amelanotic and hypomelanotic melanoma.
    Stojkovic-Filipovic J; Kittler H
    J Dtsch Dermatol Ges; 2014 Jun; 12(6):467-72. PubMed ID: 24825465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amelanotic melanoma.
    Gong HZ; Zheng HY; Li J
    Melanoma Res; 2019 Jun; 29(3):221-230. PubMed ID: 30672881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological and dermoscopic features of amelanotic and hypomelanotic melanoma: a retrospective multicentric study.
    Paolino G; Bearzi P; Pampena R; Longo C; Frascione P; Rizzo N; Raucci M; Carbone A; Cantisani C; Ricci F; Didona D; Frattini F; Bulotta A; Gregorc V; Mercuri SR
    Int J Dermatol; 2020 Nov; 59(11):1371-1380. PubMed ID: 32726478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRAF and KIT somatic mutations are present in amelanotic melanoma.
    Massi D; Pinzani P; Simi L; Salvianti F; De Giorgi V; Pizzichetta MA; Mirri F; Steffan A; Orlando C; Santucci M; Canzonieri V
    Melanoma Res; 2013 Oct; 23(5):414-9. PubMed ID: 23938765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iris pigmented lesions as a marker of cutaneous melanoma risk: an Australian case-control study.
    Laino AM; Berry EG; Jagirdar K; Lee KJ; Duffy DL; Soyer HP; Sturm RA
    Br J Dermatol; 2018 May; 178(5):1119-1127. PubMed ID: 29315480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of 8q24 copy number gains and c-MYC expression in amelanotic cutaneous melanoma.
    Pouryazdanparast P; Brenner A; Haghighat Z; Guitart J; Rademaker A; Gerami P
    Mod Pathol; 2012 Sep; 25(9):1221-6. PubMed ID: 22555175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dermoscopic clues in the diagnosis of amelanotic and hypomelanotic malignant melanoma.
    Steglich RB; Meotti CD; Ferreira MS; Lovatto L; de Carvalho AV; de Castro CG
    An Bras Dermatol; 2012; 87(6):920-3. PubMed ID: 23197217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dermoscopic evaluation of nodular melanoma.
    Menzies SW; Moloney FJ; Byth K; Avramidis M; Argenziano G; Zalaudek I; Braun RP; Malvehy J; Puig S; Rabinovitz HS; Oliviero M; Cabo H; Bono R; Pizzichetta MA; Claeson M; Gaffney DC; Soyer HP; Stanganelli I; Scolyer RA; Guitera P; Kelly J; McCurdy O; Llambrich A; Marghoob AA; Zaballos P; Kirchesch HM; Piccolo D; Bowling J; Thomas L; Terstappen K; Tanaka M; Pellacani G; Pagnanelli G; Ghigliotti G; Ortega BC; Crafter G; Ortiz AM; Tromme I; Karaarslan IK; Ozdemir F; Tam A; Landi C; Norton P; Kaçar N; Rudnicka L; Slowinska M; Simionescu O; Di Stefani A; Coates E; Kreusch J
    JAMA Dermatol; 2013 Jun; 149(6):699-709. PubMed ID: 23553375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amelanotic melanomas presenting as red skin lesions: a diagnostic challenge with potentially lethal consequences.
    McClain SE; Mayo KB; Shada AL; Smolkin ME; Patterson JW; Slingluff CL
    Int J Dermatol; 2012 Apr; 51(4):420-6. PubMed ID: 22435430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dermoscopy, reflectance confocal microscopy and histopathology of an amelanotic melanoma from an individual heterozygous for MC1R and tyrosinase variant alleles.
    Curchin C; Wurm E; Jagirdar K; Sturm R; Soyer P
    Australas J Dermatol; 2012 Nov; 53(4):291-4. PubMed ID: 22497519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.